PNC Financial Services Group
NVCR icon

PNC Financial Services Group’s NovoCure NVCR Stock Holding History

PNC Financial Services Group’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.68K Buy
796
+480
+152% +$6K ﹤0.01% 4019
2025
Q4 		$4.09K Sell
316
-70
-18% -$899 ﹤0.01% 4313
2025
Q3 		$4.99K Sell
386
-1,202
-76% -$16.1K ﹤0.01% 4205
2025
Q2 		$28.3K Sell
1,588
-516
-25% -$8.99K ﹤0.01% 3407
2025
Q1 		$37.5K Sell
2,104
-28
-1% -$636 ﹤0.01% 3252
2024
Q4 		$63.5K Sell
2,132
-276
-11% -$5.84K ﹤0.01% 2959
2024
Q3 		$37.6K Buy
2,408
+530
+28% +$9.61K ﹤0.01% 3222
2024
Q2 		$32.2K Buy
1,878
+675
+56% +$11.9K ﹤0.01% 3256
2024
Q1 		$18.8K Buy
1,203
+328
+37% +$4.82K ﹤0.01% 3479
2023
Q4 		$13.1K Sell
875
-4,647
-84% -$62.2K ﹤0.01% 3633
2023
Q3 		$89.2K Buy
5,522
+1,461
+36% +$42.1K ﹤0.01% 2642
2023
Q2 		$169K Sell
4,061
-66
-2% -$4.1K ﹤0.01% 2324
2023
Q1 		$248K Buy
4,127
+6
+0.1% +$479 ﹤0.01% 2002
2022
Q4 		$302K Sell
4,121
-6
-0.1% -$451 ﹤0.01% 1851
2022
Q3 		$314K Buy
4,127
+41
+1% +$3.2K ﹤0.01% 1798
2022
Q2 		$283K Sell
4,086
-994
-20% -$74.9K ﹤0.01% 1913
2022
Q1 		$421K Sell
5,080
-1,931
-28% -$142K ﹤0.01% 1786
2021
Q4 		$527K Buy
7,011
+1,162
+20% +$117K ﹤0.01% 1653
2021
Q3 		$680K Sell
5,849
-4,994
-46% -$755K ﹤0.01% 1426
2021
Q2 		$2.4M Buy
10,843
+602
+6% +$117K ﹤0.01% 853
2021
Q1 		$1.35M Sell
10,241
-108
-1% -$17.1K ﹤0.01% 1039
2020
Q4 		$1.79M Buy
10,349
+58
+0.6% +$7.94K ﹤0.01% 881
2020
Q3 		$1.15M Sell
10,291
-2,225
-18% -$178K ﹤0.01% 986
2020
Q2 		$743K Buy
12,516
+12,357
+7,772% +$813K ﹤0.01% 1166
2020
Q1 		$10K Sell
159
-286
-64% -$22.6K ﹤0.01% 3405
2019
Q4 		$37K Sell
445
-12,441
-97% -$1M ﹤0.01% 3066
2019
Q3 		$963K Sell
12,886
-8,090
-39% -$647K ﹤0.01% 1275
2019
Q2 		$1.33M Buy
20,976
+16,826
+405% +$853K ﹤0.01% 1167
2019
Q1 		$200K Sell
4,150
-4,520
-52% -$218K ﹤0.01% 2145
2018
Q4 		$290K Buy
8,670
+5,309
+158% +$194K ﹤0.01% 1841
2018
Q3 		$176K Sell
3,361
-3,919
-54% -$156K ﹤0.01% 2260
2018
Q2 		$228K Buy
7,280
+1,100
+18% +$30.6K ﹤0.01% 2114
2018
Q1 		$134K Buy
6,180
+800
+15% +$17.2K ﹤0.01% 2402
2017
Q4 		$108K Buy
+5,380
New +$104K ﹤0.01% 2524
2016
Q4 		– Sell
-800
Closed -$6K – 4060
2016
Q3 		$6K Hold
800
– – ﹤0.01% 3636
2016
Q2 		$10K Hold
800
– – ﹤0.01% 3558
2016
Q1 		$12K Sell
800
-200
-20% -$2.87K ﹤0.01% 3499
2015
Q4 		$22K Buy
+1,000
New +$23.9K ﹤0.01% 3258

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

PNC Financial Services Group's NVCR Position: Q1 2026 in Review

PNC Financial Services Group increased its NovoCure (NVCR) stake by 152% in Q1 2026, buying an estimated $6K and bringing the position to 796 shares worth $8.68K. The position accounts for ﹤0.01% of the portfolio, ranked #4019.

PNC Financial Services Group first reported a position in NVCR in Q4 2015 and has held it in 38 quarters since. The position peaked at $2.4M in Q2 2021. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • PNC Financial Services Group held 796 shares of NovoCure worth $8.68K as of Q1 2026.
  • PNC Financial Services Group bought 480 NovoCure shares in Q1 2026, an estimated $6K.
  • NovoCure made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4019 holding.
  • PNC Financial Services Group first reported a position in NovoCure in Q4 2015 and has held it in 38 quarters since.
  • PNC Financial Services Group's NovoCure position peaked at $2.4M in Q2 2021.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.